| # | Title | Journal | Year | Citations |
|---|
| 1 | The skin prick test – European standards | Clinical and Translational Allergy | 2013 | 562 |
| 2 | Fungal allergy in asthma–state of the art and research needs | Clinical and Translational Allergy | 2014 | 264 |
| 3 | Diagnostic tools in Rhinology EAACI position paper | Clinical and Translational Allergy | 2011 | 156 |
| 4 | Mechanisms of allergen‐specific immunotherapy | Clinical and Translational Allergy | 2012 | 154 |
| 5 | The role of IL‐33 and mast cells in allergy and inflammation | Clinical and Translational Allergy | 2015 | 152 |
| 6 | Pollen and spore monitoring in the world | Clinical and Translational Allergy | 2018 | 149 |
| 7 | Research needs in allergy: an EAACI position paper, in collaboration with EFA | Clinical and Translational Allergy | 2012 | 127 |
| 8 | ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle | Clinical and Translational Allergy | 2016 | 121 |
| 9 | Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis | Clinical and Translational Allergy | 2019 | 120 |
| 10 | Endotype-driven treatment in chronic upper airway diseases | Clinical and Translational Allergy | 2017 | 117 |
| 11 | Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease | Clinical and Translational Allergy | 2014 | 112 |
| 12 | Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper | Clinical and Translational Allergy | 2020 | 110 |
| 13 | Food allergies in developing and emerging economies: need for comprehensive data on prevalence rates | Clinical and Translational Allergy | 2012 | 108 |
| 14 | Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report | Clinical and Translational Allergy | 2017 | 107 |
| 15 | Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP—an international interpretation of the MAP (Milk Allergy in Primary Care) guideline | Clinical and Translational Allergy | 2017 | 107 |
| 16 | Diagnosis and management of non‐IgE‐mediated cow's milk allergy in infancy ‐ a UK primary care practical guide | Clinical and Translational Allergy | 2013 | 105 |
| 17 | MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence | Clinical and Translational Allergy | 2018 | 104 |
| 18 | EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy | Clinical and Translational Allergy | 2012 | 97 |
| 19 | The impact of cold on the respiratory tract and its consequences to respiratory health | Clinical and Translational Allergy | 2018 | 97 |
| 20 | Is diet partly responsible for differences in COVID-19 death rates between and within countries? | Clinical and Translational Allergy | 2020 | 97 |
| 21 | Schnitzler's syndrome: lessons from 281 cases | Clinical and Translational Allergy | 2014 | 92 |
| 22 | Prolonged efficacy of the 300IR 5‐grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score | Clinical and Translational Allergy | 2015 | 92 |
| 23 | Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy | Clinical and Translational Allergy | 2015 | 91 |
| 24 | Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases | Clinical and Translational Allergy | 2019 | 87 |
| 25 | Basophil activation test: food challenge in a test tube or specialist research tool? | Clinical and Translational Allergy | 2016 | 86 |
| 26 | The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey | Clinical and Translational Allergy | 2015 | 82 |
| 27 | Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma | Clinical and Translational Allergy | 2019 | 81 |
| 28 | Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America | Clinical and Translational Allergy | 2017 | 79 |
| 29 | Impact of Aspergillus fumigatus in allergic airway diseases | Clinical and Translational Allergy | 2011 | 76 |
| 30 | Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice | Clinical and Translational Allergy | 2012 | 72 |
| 31 | Incidence and risk factors for food hypersensitivity in UK infants: results from a birth cohort study | Clinical and Translational Allergy | 2015 | 72 |
| 32 | Grass pollen allergy in children and adolescents‐symptoms, health related quality of life and the value of pollen prognosis | Clinical and Translational Allergy | 2013 | 71 |
| 33 | Component resolved diagnosis: when should it be used? | Clinical and Translational Allergy | 2014 | 70 |
| 34 | POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project | Clinical and Translational Allergy | 2018 | 70 |
| 35 | Assessment of disease control in allergic rhinitis | Clinical and Translational Allergy | 2013 | 67 |
| 36 | Sensitivity to food additives, vaso‐active amines and salicylates: a review of the evidence | Clinical and Translational Allergy | 2015 | 67 |
| 37 | Non‐specific lipid‐transfer proteins: Allergen structure and function, cross‐reactivity, sensitization, and epidemiology | Clinical and Translational Allergy | 2021 | 67 |
| 38 | Prevalence of asthma in Portugal ‐ The Portuguese National Asthma Survey | Clinical and Translational Allergy | 2012 | 65 |
| 39 | Allergen‐specific immunotherapy provides immediate, long‐term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit ‐the centenary of allergen specific subcutaneous immunotherapy | Clinical and Translational Allergy | 2012 | 64 |
| 40 | Physical activity in adults with controlled and uncontrolled asthma as compared to healthy adults: a cross‐sectional study | Clinical and Translational Allergy | 2013 | 63 |
| 41 | A qPCR‐based metric of Th2 airway inflammation in asthma | Clinical and Translational Allergy | 2013 | 62 |
| 42 | Operational definitions of asthma in recent epidemiological studies are inconsistent | Clinical and Translational Allergy | 2014 | 62 |
| 43 | Not all shellfish “allergy” is allergy! | Clinical and Translational Allergy | 2011 | 61 |
| 44 | Measurement and interpretation of skin prick test results | Clinical and Translational Allergy | 2015 | 60 |
| 45 | Pathogenesis and diagnosis of delayed‐type drug hypersensitivity reactions, from bedside to bench and back | Clinical and Translational Allergy | 2015 | 60 |
| 46 | Milk: a postnatal imprinting system stabilizing FoxP3 expression and regulatory T cell differentiation | Clinical and Translational Allergy | 2016 | 60 |
| 47 | Role of the skin microbiome in atopic dermatitis | Clinical and Translational Allergy | 2014 | 58 |
| 48 | Allergic diseases in the elderly | Clinical and Translational Allergy | 2011 | 57 |
| 49 | The impact of the elimination diet on growth and nutrient intake in children with food protein induced gastrointestinal allergies | Clinical and Translational Allergy | 2016 | 57 |
| 50 | Looking forward to new targeted treatments for chronic spontaneous urticaria | Clinical and Translational Allergy | 2017 | 57 |
